According to reports from ET Now, several stocks have attracted significant analyst attention with bullish calls from brokerages. Hyundai Motor India has received a Buy rating from Elara Capital with a target price of ₹2,390, while Nestlé India has been recommended as a Buy by Nuvama with a target of ₹1,640. Vijaya Diagnostic Centre and Lemon Tree Hotels have also been identified as potential investment opportunities with target prices of ₹1,480 and ₹186 respectively.
HCL Technologies has been highlighted by Morgan Stanley with an Equal Weight rating and a target price of ₹1,410. The technology sector continues to attract attention with LG Electronics India and Havells India both receiving Buy recommendations from Goldman Sachs. However, the auto sector shows mixed signals as Voltas faces a Sell rating from the same brokerage, indicating selective caution in certain segments.
Hyundai Motor India has received an upgraded Buy rating from ICICI Securities with a revised target price of ₹2,475 (up from ₹2,250), as reported in their latest research dated June 17, 2026. The brokerage expects the company to become product aggressive with launch intensity gaining momentum over the medium term. Key whitespaces in the product portfolio including compact E-SUV, off-roader SUV, hybrids, and MPV are likely to be addressed during FY27-30, supporting growth and market share gains. For FY27, HMIL has announced plans to launch an ICE-midSUV in a high volume, high-growth segment and a compact E-SUV foray to expand addressable market, with launches possibly starting around the upcoming festive season. The company's phased expansion at the Talegaon facility in Pune should lift total capacity to 1.14 million units by FY30E, underpinning volume growth and market share recovery. Despite near-term headwinds including likely OEM price hikes by about 3 per cent and petrol price increase of 5 per cent, HMIL targets exports volume growth of 8-10 per cent for FY27 despite challenges from the West Asia crisis which accounts for 40 per cent of its exports volume.
Nestlé India faces a mixed outlook despite strong current performance, as highlighted by Systematix in their latest research report. While the company's current growth trajectory is at a multi-year high and on-ground trends remain broadly positive, growth could decelerate in H2 FY27 due to several factors. The brokerage identifies that GST-related benefits will phase out from Q3, and growth in Maggi will normalize with a high base from Q2 FY27 onwards. Additionally, input-cost inflation is monitorable, as is margin impact from high advertising and promotion, reach expansion and lower operating leverage as growth eases. Rich valuations trading at P/E of 70x/61x on FY27E/FY28E also limit a positive outlook, with the brokerage maintaining a Hold rating and valuing the stock at FY28E P/E of 65 times for a target price of ₹1,460.
